REVTx-300

N/A

Report date: 2023/05/06 11:13:34

Base Information

Drug NameREVTx-300
Drug Alias NameREVTx-300
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionTransforming growth factor beta inhibitorsInterleukin-10 modulatorsHepcidin stimulants
TargetsTransforming growth factor betaInterleukin-10Hepcidin
Therapy Area/IndicationsChronic Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevelation Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevelation Biosciences Inc
Inactive CompaniesN/A
Active IndicationsChronic Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A